Skip to main content
en
fr
Search form
Search
Main menu
About us
Our mission
Facts & Figures
Our Strategy
Corporate Governance/ Executive Committee
bioMérieux Worldwide
Our History
Innovation
Institut Mérieux
Responsibility
Our commitments
Responsibility to society
Responsibility to our workforce
Responsibility to the environment
Ethics & Compliance
Sustainable and socially inclusive purchasing
Global Compact
Internal Audit & Risks
FONDATION MÉRIEUX
OUR EMPLOYEE'S SUCCESS
Solutions
Clinical Solutions
Industry Solutions
Product Quality & Safety
Customer Service
Cybersecurity & data privacy
Technical Library
CLINICAL SOLUTIONS
INDUSTRY SOLUTIONS
Expertise
The importance of diagnostics
Clinical diagnostics
Industrial Microbiological Control
Clinical applications
Infectious diseases
COVID-19
Antimicrobial resistance and Healthcare-associated infections
Cardiovascular Emergencies
Personalized medicine
Industrial applications
Agri-food sector
Biopharma & cosmetics sectors
Our technologies, systems and services
Microbiology
Molecular Biology
Immunoassays
Laboratory efficiency
Glossary of Scientific Terms
Education
Antimicrobial Resistance / Antimicrobial Stewardship
Webinars
Educational Materials
External Resources
Sepsis / Bloodstream Infections
Webinars
Educational Tutorials
Educational Materials
External Resources
COVID-19
Webinars
Educational booklets
Investors
The bioMérieux Share
Publications
Regulated Information
Governance
Shareholder area
UNIVERSAL REGISTRATION DOCUMENT
CORPORATE SOCIAL RESPONSIBILITY
Newsroom
Press Releases
Corporate calendar
Media Center
About bioMérieux
BIOASTER, Université de Technologie de Compiègne, Hospices Civils de Lyon and bioMérieux formalize strategic collaboration to conduct Next Generation Sequencing technology evaluation in microbiology.
PRESS CONTACTS
Careers
Joining bioMérieux
Corporate culture
Public health mission
International presence
Professional development
Diversity and inclusion
Well-being at work
Compensation and benefits
Job Profiles
R&D
Manufacturing
Supply Chain
Information Systems
Quality
Business
Support Functions
Medical Affairs
HSE
Clinical Affairs and Regulatory Affairs
Contact us
About us
Our mission
Facts & Figures
Our Strategy
Corporate Governance/ Executive Committee
bioMérieux Worldwide
Our History
Innovation
Institut Mérieux
Responsibility
Our commitments
Responsibility to society
Responsibility to our workforce
Responsibility to the environment
Ethics & Compliance
Sustainable and socially inclusive purchasing
Global Compact
Internal Audit & Risks
Solutions
Clinical Solutions
Industry Solutions
Product Quality & Safety
Customer Service
Cybersecurity & data privacy
Technical Library
Expertise
The importance of diagnostics
Clinical applications
Industrial applications
Our technologies, systems and services
Glossary of Scientific Terms
Education
Antimicrobial Resistance / Antimicrobial Stewardship
Sepsis / Bloodstream Infections
COVID-19
Educational booklets
Investors
The bioMérieux Share
Publications
Regulated Information
Governance
Shareholder area
Newsroom
Press Releases
Corporate calendar
Media Center
About bioMérieux
Careers
Joining bioMérieux
Job Profiles
Contact us
Investor Relations
Press Contacts
en
fr
Search form
Search
bioMérieux Corporate Website |
Pioneering diagnostics
Philanthropy
Covid-19 Exceptional Donations: discover the actions supported by bioMérieux to help people made vulnerable by the health crisis.
WAAW 2020 - November 18th-24th
World Antimicrobial Awareness Week: we are proud to renew our support to this WHO initiative! Find out more
2020 BFM Awards
Alexandre Mérieux, 2020 BFM Award laureate in the family saga category.
Investors
Discover our investors-dedicated section
Press releases
December 02, 2020
BIOASTER, Université de Technologie de Compiègne, Hospices Civils
...
November 16, 2020
bioMérieux announces
the expansion of the CE marking of its molecu
...
October 22, 2020
bioMérieux – Third-Quarter 2020 Business Review
October 08, 2020
AMSP partners with bioMérieux to facilitate supply of high-quality...
